One will test treatments for sleep problems. Two additional studies will open in the coming months. They include Posit Science Corp.’s BrainHQ cognitive training program, another called PASC-Cognitive Recovery by New York City’s Mount Sinai Health System, and a Soterix Medical device that electrically stimulates brain circuits. Treatments for “brain fog” and other cognitive problems. Normally Paxlovid is used when people first get COVID-19 and for just five days. Whether taking up to 25 days of Pfizer's antiviral drug Paxlovid could ease long COVID, because of a theory that some live coronavirus, or its remnants, may hide in the body and trigger the disorder. That's why so far the RECOVER initiative has tracked 24,000 patients in observational studies to help define the most common and burdensome symptoms - findings that now are shaping multipronged treatment trials. Health and Human Services Secretary Xavier Becerra said. “If I get 10 people, I get 10 answers of what long COVID really is," U.S. Between 10% and 30% of people are estimated to have experienced some form of long COVID after recovering from a coronavirus infection, a risk that has dropped somewhat since early in the pandemic. Scientists don’t yet know what causes long COVID, the catchall term for about 200 widely varying symptoms. Getting answers is critical, he added, because “there’s a lot of people out there exploiting patients’ vulnerability” with unproven therapies. Louis, who isn’t involved with NIH’s project but whose own research highlighted long COVID’s toll. Ziyad Al-Aly of Washington University in St. “This is a year or two late and smaller in scope than one would hope but nevertheless it’s a step in the right direction,” said Dr. Monday’s announcement from the NIH’s $1.15 billion RECOVER project comes amid frustration from patients who’ve struggled for months or even years with sometimes-disabling health problems - with no proven treatments and only a smattering of rigorous studies to test potential ones. efforts against the mysterious condition that afflicts millions. WASHINGTON - The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |